The Post and other publications picked up CQ-Roll Call's Andrew Siddons' analysis of the potential impact of federal Right-To-Try legislation. Read the article here: the Reagan-Udall Foundation and Navigator are part of the concluding paragraphs about steps FDA has taken to improve the existing expanded access process. Note: the Foundation does not take a position on legislation or influence regulation.